ArticlePakistan journal of medical sciences2025
Evaluation of Metabolic and Cardiovascular Risks in patients with Prediabetes: Cross-sectional study.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of neuropsychological characteristics and related influencing factors in patients with vascular cognitive impairment.Pakistan journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the metabolic and cardiovascular risk of patients with prediabetes (pre-D) compared to type two diabetes mellitus (T2DM) patients and healthy subjects, and to predict cardiovascular risk associated with glycemic disturbance. Methodology: In this cross-sectional study, eighty patients with prediabetes were compared with ninety T2DM and one hundred healthy individuals as controls enrolled from the University Medical Center, Taibah University, Madinah, Kingdom of Saudi Arabia, from 23 June 2024 to 06 February 2025. Biochemical (FPG, HbA1c, insulin, and lipid profiles), anthropometric (BMI, WC, F%, FM, and FFM), and clinical (blood pressure, smoking, and education status) profiles were measured. Results: Pre-D and T2DM groups had significantly higher BMI, F%, FM, FPG, HbA1c, insulin, and TG than controls (p <0.01). Regression analysis showed that BMI, F%, FM, FPG and insulin are independent predictors of pre-D risk (p <0.001); moreover, crosstabs revealed the assessment of cardiovascular risk which revealed significant high odds ratios in pre-D subjects with hypertension (OR = 31.7), hyperglycemia (OR = 40), metabolic syndrome (OR = 35), smoking (OR = 55) and obesity (OR = 64.7). Conclusion: Pre-D exhibited significant metabolic alterations and higher risk for cardiovascular disease, which necessitates early screening and treatment. Factors like smoking and high blood pressure increase cardiovascular risk, while factors related to adiposity and insulin resistance influence glycemic levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.